Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

健民 - NMPA Drug Approval Details

Approvals/NMPA/健民

Approved

中药

健民

健民药业集团股份有限公司,健民集团叶开泰国药(随州)有限公司🇨🇳 National Medical Products Administration

Approval Date: Jun 16, 2020
Approval ID: 7LeaeQoS2ou
Company: 健民药业集团股份有限公司,健民集团叶开泰国药(随州)有限公司
Type: 中药

Approval Details

Approval Id: 7LeaeQoS2ou
Approval Number: 国药准字Z19990071
Generic Name: 便通胶囊
Brand Name: 健民
Drug Type: 中药
Dosage Form: 胶囊剂
Strength: 每粒装0.35g
Reg Date: 2020-06-16
Company Name: 健民药业集团股份有限公司,健民集团叶开泰国药(随州)有限公司
Production Company Name: 健民药业集团股份有限公司,健民集团叶开泰国药(随州)有限公司
Production Company Address: 湖北省武汉市汉阳区鹦鹉大道484号,湖北省随州高新技术产业园区

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 16, 2020

Approval ID

7LeaeQoS2ou

Type

中药

Back to NMPA Approvals